TopoGEN Topoisomerase Assay Kits

Tuesday, 08 April, 2025 | Supplied by: Sapphire Bioscience

Topoisomerases are enzymes that reduce DNA supercoiling by introducing cuts in DNA strands. TopoGEN recognises the unique details of topoisomerase drug discovery and provides innovative reagents and kits for topoisomerase research and mechanism-based drug development in cancer.

Kits are available to assay for topoisomerases (I, II, IV and gyrase) and Tdp1, to measure topo/DNA interactions in vivo and to identify new topoisomerase drugs. The company also offers a complete line of DNA substrates topo inhibitors, antibodies and kit replenishment reagents.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Content from other channels on our network

The Data-Ready Foundation for an AI-Powered Healthcare Future

Innovating chemical dosing & dilution in aged care

A shift in clinical practice: optimal antibiotics for golden staph bloodstream infections

The rise of non-clinical, community-led safe spaces: how lived experience is reshaping suicide prevention

Mandatory VR violence training for nursing students

Detoxifying 'super fungi' may recover critical minerals

Training centre opens to improve alloy lifecycle

Water utilities know where AI fits — but can the foundations carry it?

FIFA World Cup to generate 156 tonnes of plastic waste

Collaboration provides NZ's largest smart water meter upgrade

Deakin University launches metal resources research centre

Dragos introduces OT-native cybersecurity AI

Construction begins on south‍-‍west WA advanced manufacturing hub

Newcastle carbon capture plant opens

Accenture acquires Dragos and increases OT cybersecurity offering

TopoGEN Topoisomerase Assay Kits

Invent Biotechnologies Minute Single Cell Nuclei Kits

MP Biomedicals MagBeads FastDNA MaxPure Kit for Feces and Fecal Preservation Solution

Enzo Life Sciences Histamine ELISA Kit

Content from other channels on our network